SPAG16 Activators are a diverse group of chemical compounds that indirectly augment the functional activity of SPAG16 through the modulation of various signaling pathways, primarily those mediated by cyclic nucleotides. Compounds like Forskolin, 3-Isobutyl-1-methylxanthine, Zaprinast, Sildenafil Citrate, Cilostamide, Pentoxifylline, Luteolin, and Rolipram act as phosphodiesterase inhibitors or adenylyl cyclase activators, leading to increased cellular levels of cyclic AMP (cAMP). The elevated cAMP levels activate protein kinase A (PKA), a kinase that phosphorylates a host of proteins involved in sperm motility, a process in which SPAG16 is intricatelyinvolved. By enhancing PKA signaling, these activators indirectly support SPAG16's role in the regulation of microtubule-based movement and capacitation in sperm, which are critical for its motility and fertility functions. Additionally, the use of cAMP analogs like Dibutyryl cAMP and Sp-5'-CPT-cAMPS bypasses the need for upstream activation and directly stimulates PKA, leading to a similar enhancement of SPAG16 functionality. Myristic Acid plays a different but complementary role by participating in the post-translational modification of proteins; it may facilitate the proper localization and function of SPAG16 through myristoylation, ensuring the protein is correctly situated within sperm cells to exert its effects on motility.
Collectively, these SPAG16 Activators work in concert to maintain and enhance the activity of this protein critical for sperm function. The precise modulation of cAMP levels and PKA activation is a central theme among these activators, illustrating the importance of this signaling axis in SPAG16's role. While the majority of these compounds increase intracellular cAMP, either by inhibiting its degradation or stimulating its production, the outcomes are uniformly aimed at enhancing the phosphorylation events that boost SPAG16's activity. The strategic influence over these biochemical pathways underscores the potential of these compounds to indirectly yet effectively enhance the functional activity of SPAG16, specifically targeting the regulation of sperm motility and capacitation essential.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Forskolin | 66575-29-9 | sc-3562 sc-3562A sc-3562B sc-3562C sc-3562D | 5 mg 50 mg 1 g 2 g 5 g | $78.00 $153.00 $740.00 $1413.00 $2091.00 | 73 | |
Forskolin activates adenylyl cyclase, leading to increased cAMP levels in cells. Elevated cAMP activates PKA, which can phosphorylate proteins involved in sperm motility, potentially enhancing the function of SPAG16 in sperm flagella. | ||||||
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
This compound is a phosphodiesterase inhibitor that prevents the breakdown of cAMP. By maintaining high levels of cAMP, it indirectly supports the PKA signaling pathway, which may augment the role of SPAG16 in sperm motility. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast is another phosphodiesterase inhibitor that increases cAMP levels. By a similar mechanism to 3-Isobutyl-1-methylxanthine, it could enhance SPAG16's functional role in the regulation of microtubule-based movement in sperm. | ||||||
Cilostamide (OPC 3689) | 68550-75-4 | sc-201180 sc-201180A | 5 mg 25 mg | $92.00 $357.00 | 16 | |
Cilostamide is a selective phosphodiesterase 3 inhibitor, leading to increased cAMP levels in cells, potentially enhancing the PKA signaling pathway and SPAG16's role in sperm motility. | ||||||
Pentoxifylline | 6493-05-6 | sc-203184 | 1 g | $20.00 | 3 | |
Pentoxifylline is a phosphodiesterase inhibitor that increases cAMP by preventing its degradation, potentially enhancing the PKA signaling pathway and subsequently the activity of SPAG16. | ||||||
Luteolin | 491-70-3 | sc-203119 sc-203119A sc-203119B sc-203119C sc-203119D | 5 mg 50 mg 500 mg 5 g 500 g | $27.00 $51.00 $101.00 $153.00 $1925.00 | 40 | |
Luteolin is a flavonoid that can inhibit PDE and activate PKA. This activation can lead to phosphorylation of downstream targets involved in sperm motility, potentially enhancing the activity of SPAG16. | ||||||
Myristic Acid | 544-63-8 | sc-205393 sc-205393A sc-205393B | 1 g 5 g 50 g | $31.00 $77.00 $306.00 | 1 | |
Myristic Acid is involved in protein myristoylation, a modification that can affect protein function and localization. SPAG16, through myristoylation, might be properly localized and activated in sperm cells. | ||||||
Rolipram | 61413-54-5 | sc-3563 sc-3563A | 5 mg 50 mg | $77.00 $216.00 | 18 | |
Rolipram is a selective PDE4 inhibitor that elevates cAMP levels, potentially enhancing the PKA signaling and the activity of SPAG16 in the regulation of sperm motility. | ||||||
Dibutyryl-cAMP | 16980-89-5 | sc-201567 sc-201567A sc-201567B sc-201567C | 20 mg 100 mg 500 mg 10 g | $47.00 $136.00 $492.00 $4552.00 | 74 | |
Dibutyryl cAMP is a cAMP analog that directly activates PKA. PKA activation can then phosphorylate proteins that are involved in the regulation of sperm motility, which might enhance the activity of SPAG16. | ||||||